Humacyte’s (HUMA) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital restated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note released on Monday morning,Benzinga reports. The brokerage currently has a $25.00 price objective on the stock. Other equities analysts also recently issued reports about the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $13.00 […]
More Stories
McDonald’s Co. (NYSE:MCD) Shares Bought by Mason & Associates Inc
Mason & Associates Inc increased its holdings in McDonald’s Co. (NYSE:MCD – Free Report) by 10.3% during the fourth quarter,...
Rep. Josh Gottheimer Acquires Shares of Thermon Group Holdings, Inc. (NYSE:THR)
Representative Josh Gottheimer (D-New Jersey) recently bought shares of Thermon Group Holdings, Inc. (NYSE:THR). In a filing disclosed on January...
Pinnacle Bancorp Inc. Has $7.62 Million Stake in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Pinnacle Bancorp Inc. boosted its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 1.9%...
Sendero Wealth Management LLC Has $506,000 Stake in Merck & Co., Inc. (NYSE:MRK)
Sendero Wealth Management LLC lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 9.7%...
Builder Investment Group Inc. ADV Has $8.35 Million Stock Position in Marsh & McLennan Companies, Inc. (NYSE:MMC)
Builder Investment Group Inc. ADV decreased its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report)...
Short Interest in TIS Inc. (OTCMKTS:TISNF) Increases By 54.4%
TIS Inc. (OTCMKTS:TISNF – Get Free Report) saw a large growth in short interest during the month of December. As...